These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11457844)

  • 1. Induction of angiogenesis by expression of soluble type II transforming growth factor-beta receptor in mouse hepatoma.
    Kim KY; Jeong SY; Won J; Ryu PD; Nam MJ
    J Biol Chem; 2001 Oct; 276(42):38781-6. PubMed ID: 11457844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of endogenous TGF-beta effect induces mouse hepatoma malignancy by correlation with cyclooxygenase-2 and VEGF.
    Kim KY; Lee JW; Ahn BW; Ryu PD; Nam MJ
    Hepatol Res; 2003 Aug; 26(4):302-310. PubMed ID: 12963430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway.
    Shen BQ; Lee DY; Zioncheck TF
    J Biol Chem; 1999 Nov; 274(46):33057-63. PubMed ID: 10551875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis.
    Breier G; Blum S; Peli J; Groot M; Wild C; Risau W; Reichmann E
    Int J Cancer; 2002 Jan; 97(2):142-8. PubMed ID: 11774256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.
    Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Miyamoto Y; Kawata M; Ikenaka Y; Nakatani T; Tsujinoue H; Fukui H
    Hepatology; 1999 Nov; 30(5):1179-86. PubMed ID: 10534339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over expression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis.
    Banerjee SK; Sarkar DK; Weston AP; De A; Campbell DR
    Carcinogenesis; 1997 Jun; 18(6):1155-61. PubMed ID: 9214597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.
    Boocock CA; Charnock-Jones DS; Sharkey AM; McLaren J; Barker PJ; Wright KA; Twentyman PR; Smith SK
    J Natl Cancer Inst; 1995 Apr; 87(7):506-16. PubMed ID: 7707437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS).
    Tanimoto T; Jin ZG; Berk BC
    J Biol Chem; 2002 Nov; 277(45):42997-3001. PubMed ID: 12226078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms.
    Plate KH; Breier G; Weich HA; Mennel HD; Risau W
    Int J Cancer; 1994 Nov; 59(4):520-9. PubMed ID: 7525492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
    Maruyama K; Mori Y; Murasawa S; Masaki H; Takahashi N; Tsutusmi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Shibuya M; Inada M; Matsubara H; Iwasaka T
    J Mol Cell Cardiol; 1999 Mar; 31(3):607-17. PubMed ID: 10198191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications.
    Giatromanolaki A; Sivridis E; Brekken R; Thorpe PE; Anastasiadis P; Gatter KC; Harris AL; Koukourakis MI;
    Cancer; 2001 Nov; 92(10):2569-77. PubMed ID: 11745191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro.
    Shen BQ; Lee DY; Gerber HP; Keyt BA; Ferrara N; Zioncheck TF
    J Biol Chem; 1998 Nov; 273(45):29979-85. PubMed ID: 9792718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors.
    McCabe CJ; Boelaert K; Tannahill LA; Heaney AP; Stratford AL; Khaira JS; Hussain S; Sheppard MC; Franklyn JA; Gittoes NJ
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4238-44. PubMed ID: 12213878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer.
    Itakura J; Ishiwata T; Shen B; Kornmann M; Korc M
    Int J Cancer; 2000 Jan; 85(1):27-34. PubMed ID: 10585578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.
    Iglesias-de la Cruz MC; Ziyadeh FN; Isono M; Kouahou M; Han DC; Kalluri R; Mundel P; Chen S
    Kidney Int; 2002 Sep; 62(3):901-13. PubMed ID: 12164872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling.
    Komuro A; Yashiro M; Iwata C; Morishita Y; Johansson E; Matsumoto Y; Watanabe A; Aburatani H; Miyoshi H; Kiyono K; Shirai YT; Suzuki HI; Hirakawa K; Kano MR; Miyazono K
    J Natl Cancer Inst; 2009 Apr; 101(8):592-604. PubMed ID: 19351925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR).
    Kroll J; Waltenberger J
    Biochem Biophys Res Commun; 1998 Nov; 252(3):743-6. PubMed ID: 9837777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer.
    Takahashi Y; Cleary KR; Mai M; Kitadai Y; Bucana CD; Ellis LM
    Clin Cancer Res; 1996 Oct; 2(10):1679-84. PubMed ID: 9816116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the acute myeloid leukemia cell line OCI/AML-2 by endothelial nitric oxide synthase under the control of a vascular endothelial growth factor signaling system.
    Koistinen P; Siitonen T; Mäntymaa P; Säily M; Kinnula V; Savolainen ER; Soini Y
    Leukemia; 2001 Sep; 15(9):1433-41. PubMed ID: 11516104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.